133 Participants Needed

Transition Coaching for Juvenile Arthritis

(TRACER Trial)

Recruiting at 1 trial location
MB
Overseen ByMichelle Batthish, MD
Age: < 65
Sex: Any
Trial Phase: Academic
Sponsor: McMaster University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Transition Coaching for Juvenile Arthritis?

Research shows that structured transition programs, like transition coaching, help young people with juvenile arthritis move smoothly from pediatric to adult care, reducing drop-out rates and improving self-management skills.12345

Is transition coaching for juvenile arthritis safe?

The research does not specifically address the safety of transition coaching, but it highlights the importance of structured transition programs for young adults with rheumatic diseases. These programs aim to improve care and outcomes, suggesting they are generally considered safe and beneficial.12678

How is transition coaching different from other treatments for juvenile arthritis?

Transition coaching is unique because it focuses on helping young people with juvenile arthritis move smoothly from pediatric to adult healthcare. It includes education, counseling, and support for life changes, unlike traditional treatments that mainly focus on managing physical symptoms.13489

What is the purpose of this trial?

TRACER is a study aiming to investigate the feasibility of transition coaching sessions for patients moving from paediatric to adult rheumatology care.

Research Team

MB

Michelle Batthish, MD

Principal Investigator

McMaster University

Eligibility Criteria

This trial is for young people with pediatric-onset rheumatic diseases like arthritis and lupus, who are transitioning to adult care. Participants need a phone or device for video calls, must be available for the next 8 months, and able to communicate in English. Those with cognitive impairments that prevent participation in educational sessions cannot join.

Inclusion Criteria

I had my last pediatric rheumatology appointment before moving to adult care.
Able to communicate in English
Have a phone or device capable of participating in video conference
See 2 more

Exclusion Criteria

My thinking or memory problems prevent me from learning new health information.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Transition Coaching

Participants receive 8 transition coaching sessions (1/month) in addition to standard care

8 months
8 visits (virtual)

Follow-up

Participants are monitored for safety and effectiveness after transition coaching

3 years

Treatment Details

Interventions

  • Transition coaching
Trial Overview The TRACER study is testing transition coaching sessions designed to help patients move from pediatric to adult rheumatology care smoothly. The feasibility of these coaching interventions through video conferencing will be evaluated.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Transition coaching - experimentalExperimental Treatment1 Intervention
Participants will receive 8 transition coaching sessions (1/month) in addition to standard care
Group II: Standard care - controlActive Control1 Intervention
Standard of care, appointments with adult rheumatology

Find a Clinic Near You

Who Is Running the Clinical Trial?

McMaster University

Lead Sponsor

Trials
936
Recruited
2,630,000+

Western University

Collaborator

Trials
31
Recruited
129,000+

Findings from Research

The implementation of a clinical transition pathway for young people with juvenile-onset rheumatic and musculoskeletal diseases significantly reduced the drop-out rate from 35% to just 5.1% in the adult clinic and 1.3% in the dedicated adolescent JIA-clinic, indicating improved patient retention during the transition process.
Young people reported high satisfaction with the transition process, scoring an average of 7.7 and 7.5 on satisfaction scales, and demonstrated strong self-management skills, with self-efficacy scores of 59.7 and 58.2, suggesting they feel confident in managing their condition post-transition.
Successful implementation of a clinical transition pathway for adolescents with juvenile-onset rheumatic and musculoskeletal diseases.Walter, M., Kamphuis, S., van Pelt, P., et al.[2018]
The scoping review identified significant gaps in transition research for young adults with rheumatic diseases, particularly the lack of longitudinal studies confirming the effectiveness of existing transition readiness scales.
Multimodal interventions are shown to be the most effective in improving transition outcomes, and future research should focus on enhancing self-efficacy and health literacy, as well as identifying young adults with psychosocial vulnerabilities to support their transition to adult care.
Pediatric to Adult Transition Literature: Scoping Review and Rheumatology Research Prioritization Survey Results.Bitencourt, N., Lawson, E., Bridges, J., et al.[2022]
Chronic inflammatory rheumatic diseases that start in childhood often continue into adulthood, leading to significant impairments in patients' daily activities and social participation, highlighting the need for ongoing healthcare into adulthood.
Effective transitions from pediatric to adult healthcare services are crucial and should be coordinated, patient-centered, and developmentally appropriate, requiring collaboration between pediatric and adult rheumatologists to address the unique needs of these patients.
[Transition clinic--it is not always a simple segue in rheumatology for adults].Minden, K., Niewerth, M., Zink, A., et al.[2022]

References

Successful implementation of a clinical transition pathway for adolescents with juvenile-onset rheumatic and musculoskeletal diseases. [2018]
Pediatric to Adult Transition Literature: Scoping Review and Rheumatology Research Prioritization Survey Results. [2022]
[Transition clinic--it is not always a simple segue in rheumatology for adults]. [2022]
[New support services for the care of young patients with rheumatic diseases]. [2019]
The coming of age of adolescent rheumatology. [2022]
Implementation of Rheumatology Health Care Transition Processes and Adaptations to Systems Under Stress: A Mixed-Methods Study. [2023]
Assessing preparation for care transition among adolescents with rheumatologic disease: a single-center assessment with patient survey. [2021]
[Transition from pediatric to adult rheumatological care]. [2018]
Adolescents with chronic disease. Transition to adult health care. [2019]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security